Table 5

Relation between participants with positive antiendomysial antibody (EMA) test result and reported morbidity

Reported morbidityOdds ratio (95% CI)
EMA resultNo (n (%))Yes (n (%))Univariatep Value*
2 test with continuity correction or Fisher’s exact test.
†Except during pregnancy.
High blood pressure†
    Negative5876 (81.4)1347 (18.6)1.0
    Positive73 (83.9)14 (16.1)0.84 (0.47–1.49)0.6
High blood cholesterol
    Negative6188 (87.6)875 (12.4)1.0
    Positive81 (93.1)6 (6.9)0.52 (0.23–1.20)0.2
Stroke
    Negative7149 (98.5)109 (1.5)1.0
    Positive85 (97.7)2 (2.3)1.54 (0.37–6.35)0.4
Heart attack and/or angina
    Negative6778 (93.3)487 (6.7)1.0
    Positive85 (97.7)2 (2.3)0.33 (0.08–1.34)0.2
CVS combined
    Negative5570 (76.6)1701 (23.4)1.0
    Positive70 (80.5)17 (19.5)0.79 (0.47–1.35)0.5
Thyroid disease
    Negative6806 (93.8)446 (6.2)1.0
    Positive80 (92.0)7 (8.0)1.33 (0.61–2.91)0.6
Diabetes
    Negative7049 (97.2)202 (2.8)1.0
    Positive86 (98.9)1 (1.1)0.41 (0.06–2.93)0.7
Fracture of the wrist
    Negative6806 (93.8)452 (6.2)1.0
    Positive80 (92.0)7 (8.0)1.32 (0.60–2.87)0.6
Bronchitis/emphysema
    Negative6125 (84.7)1110 (15.3)1.0
    Positive79 (90.8)8 (9.2)0.56 (0.27–1.16)0.2
Asthma
    Negative6520 (90.1)720 (9.9)1.0
    Positive78 (89.7)9 (10.3)1.04 (0.52–2.09)1.0
Cancer
    Negative6853 (94.5)396 (5.5)1.0
    Positive82 (94.3)5 (5.7)1.05 (0.43–2.62)0.8